Aromatic oil from lavender as an atopic dermatitis suppressant

PLoS One. 2024 Jan 5;19(1):e0296408. doi: 10.1371/journal.pone.0296408. eCollection 2024.

Abstract

In atopic dermatitis (AD), nerves are abnormally stretched near the surface of the skin, making it sensitive to itching. Expression of neurotrophic factor Artemin (ARTN) involved in such nerve stretching is induced by the xenobiotic response (XRE) to air pollutants and UV radiation products. Therefore, AD can be monitored by the XRE response. Previously, we established a human keratinocyte cell line stably expressing a NanoLuc reporter gene downstream of XRE. We found that 6-formylindolo[3,2-b]carbazole (FICZ), a tryptophan metabolite and known inducer of the XRE, increased reporter and Artemin mRNA expression, indicating that FICZ-treated cells could be a model for AD. Lavender essential oil has been used in folk medicine to treat AD, but the scientific basis for its use is unclear. In the present study, we investigated the efficacy of lavender essential oil and its major components, linalyl acetate and linalool, to suppress AD and sensitize skin using the established AD model cell line, and keratinocyte and dendritic cell activation assays. Our results indicated that lavender essential oil from L. angustifolia and linalyl acetate exerted a strong AD inhibitory effect and almost no skin sensitization. Our model is useful in that it can circumvent the practice of using animal studies to evaluate AD medicines.

MeSH terms

  • Animals
  • Dermatitis, Atopic* / drug therapy
  • Humans
  • Lavandula*
  • Monoterpenes
  • Skin

Substances

  • linalyl acetate
  • Monoterpenes

Grants and funding

This work was supported in part by MEXT/JSPS KAKENHI Grant Numbers 18K06133 and 22K06128 to A.S., and MEXT/JSPS KAKENHI Grant Numbers 17H03818 and 20H02933 to Y.N. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.